PKM and nasopharyngeal carcinoma: Expression of mutant EGFR (EGFRvIII) resulted in upregulation of a small group of genes, including FOSL1,80 and EGFR‐PKM2 signalling induced the expression of FOSL1 to promote nasopharyngeal carcinoma cell invasion and metastasis.81